Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VECODUE A Phase II Trial of Vemurafenib Plus Cobimetinib in Patients Treated With Prior First-line Systemic Immunotherapy for Inoperable Locally Advanced or Metastatic Melanoma

NCT03224208 is registered in ClinicalTrials.gov with Fondazione Melanoma Onlus as lead sponsor.

NCT NCT03224208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03224208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VECODUE A Phase II Trial of Vemurafenib Plus Cobimetinib in Patients Treated With Prior First-line Systemic Immunotherapy for Inoperable Locally Advanced or Metastatic Melanoma
Lead sponsor
Fondazione Melanoma Onlus
Phase
Phase 2
Overall status
Terminated
Start date
May 17, 2018
Completion date
January 8, 2021
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, melanoma (skin), melanoma stage